Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
AC Immune SA (ACIU)
NASDAQ:ACIU
AC Immune SA (ACIU) Stock Price & Analysis
332 Followers
ACIU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.68 - $4.93
Previous Close$2.4
Volume129.07K
Average Volume (3M)202.82K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)SFr.140.50M
Total Debt (Recent Filing)SFr.2.48M
Price to Earnings (P/E)-2.6
Beta<0.01
Next EarningsMar 21, 2023
EPS Estimate-$0.27
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$12.50
EPS (TTM)-0.94
Shares Outstanding83,413,498
R-Squared0.04
Standard Deviation0.16
10 Day Avg. Volume201,760
30 Day Avg. Volume202,821
Price to Book (P/B)1.27
Price to Sales (P/S)50.44
Price to Cash Flow (P/CF)8.90
P/FCF Ratio-3.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside429.66% Upside
Rating ConsensusModerate Buy
Alpha-0.02
Number of Analyst Covering2
AC Immune SA News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ACIU FAQ
What was AC Immune SA’s price range in the past 12 months?
AC Immune SA lowest stock price was $1.68 and its highest was $4.93 in the past 12 months.
What is AC Immune SA’s market cap?
Currently, no data Available
When is AC Immune SA’s upcoming earnings report date?
AC Immune SA’s upcoming earnings report date is Mar 21, 2023 which is in 53 days.
How were AC Immune SA’s earnings last quarter?
AC Immune SA released its earnings results on Oct 28, 2022. The company reported -$0.168 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.081.
Is AC Immune SA overvalued?
According to Wall Street analysts AC Immune SA’s price is currently Undervalued.
Does AC Immune SA pay dividends?
AC Immune SA does not currently pay dividends.
What is AC Immune SA’s EPS estimate?
AC Immune SA’s EPS estimate is -$0.27.
How many shares outstanding does AC Immune SA have?
AC Immune SA has 83,552,290 shares outstanding.
What happened to AC Immune SA’s price movement after its last earnings report?
AC Immune SA reported an EPS of -$0.168 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went down -6.452%.
Which hedge fund is a major shareholder of AC Immune SA?
Among the largest hedge funds holding AC Immune SA’s share is Platinum Investment Management. It holds AC Immune SA’s shares valued at 3M.
---
AC Immune SA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.50
$12.50
Blogger Sentiment
Bullish
ACIU Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.12%
12-Months-Change
Fundamentals
Return on Equity
-40.40%
Trailing 12-Months
Asset Growth
-4.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
---
MoonLake Immunotherapeutics
―
VectivBio Holding
―
ADC Therapeutics
―
Crispr Therapeutics AG
―
---